Menu Search
Equities

Creotech Instruments SA

5OB:DEU

Creotech Instruments SA

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Creotech Instruments SA is a Poland-based company, that operates in the space sector. The Company is a provider of space technologies and specialises in the development and manufacture of electronic products and information technology (IT) systems, such as systems based on imaging of the Earth Observation systems and UAV (Unmanned Aerial Vehicle) technology for monitoring altitude obstacles for manned and unmanned aerial vehicles and development of specialized electronics and hardware applicable in such fields as quantum computers, quantum cryptography, quantum physics and high-energy physics laboratories and microsatellites.

  • Revenue in PLN (TTM)30.68m
  • Net income in PLN-16.22m
  • Incorporated2012
  • Employees229.00
  • Location
    Creotech Instruments SAul. Jana Pawla II 66PIASECZNO 05-500PolandPOL
  • Phone+48 222464575
  • Websitehttp://creotech.pl/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.